EUVIMEDEUVIMED entdecken
Open Access

Optimal Pediatric Outpatient Antibiotic Prescribing

Brittany J Lehrer, Glodi Mutamba, Katie A Thure, Christopher D Evans, Adam L Hersh, Ritu Banerjee, Sophie E Katz

JAMA Network Open · 03.10.2024 · 7 (10) · e2437409

DOI: 10.1001/jamanetworkopen.2024.37409 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 03.10.2024. Verfasst von Brittany J Lehrer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Practice Patterns, Physicians'. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance In the US, 50% of all pediatric outpatient antibiotics prescribed are unnecessary or inappropriate. Less is known about the appropriateness of pediatric outpatient antibiotic prescribing.

Objective

To identify the overall percentage of outpatient antibiotic prescriptions that are optimal according to guideline recommendations for first-line antibiotic choice and duration. Design, Setting, and Participants This cross-sectional study obtained data on any clinical encounter for a patient younger than 20 years with at least 1 outpatient oral antibiotic, intramuscular ceftriaxone, or penicillin prescription filled in the state of Tennessee from January 1 to December 31, 2022, from IQVIA’s Longitudinal Prescription Claims and Medical Claims databases. Each clinical encounter was assigned a single diagnosis corresponding to the lowest applicable tier in a 3-tier antibiotic tier system. Antibiotics prescribed for tier 1 (nearly always required) or tier 2 (sometimes required) diagnoses were compared with published national guidelines. Antibiotics prescribed for tier 3 (rarely ever required) diagnoses were considered to be suboptimal for both choice and duration. Main Outcomes and Measures Primary outcome was the percentage of optimal antibiotic prescriptions consistent with guideline recommendations for first-line antibiotic choice and duration. Secondary outcomes were the associations of optimal prescribing by diagnosis, suboptimal antibiotic choice, and patient- and clinician-level factors (ie, age and Social Vulnerability Index) with optimal antibiotic choice, which were measured by odds ratios (ORs) and 95% CIs calculated using a multivariable logistic regression model.

Results

A total of 506 633 antibiotics were prescribed in 488 818 clinical encounters (for 247 843 females [50.7%]; mean [SD] age, 8.36 [5.5] years). Of these antibiotics, 21 055 (4.2%) were for tier 1 diagnoses, 288 044 (56.9%) for tier 2 diagnoses, and 197 660 (39.0%) for tier 3 diagnoses. Additionally, 194 906 antibiotics (38.5%) were optimal for antibiotic choice, 259 786 (51.3%) for duration, and 159 050 (31.4%) for both choice and duration. Acute otitis media (AOM) and pharyngitis were the most common indications, with 85 635 of 127 312 (67.3%) clinical encounters for AOM and 42 969 of 76 865 (55.9%) clinical encounters for pharyngitis being optimal for antibiotic choice. Only 257 of 4472 (5.7%) antibiotics prescribed for community-acquired pneumonia had a 5-day duration. Optimal antibiotic choice was more likely in patients who were younger (OR, 0.98; 95% CI, 0.98-0.98) and were less socially vulnerable (OR, 0.84; 95% CI, 0.82-0.86). Conclusions and Relevance This cross-sectional study found that less than one-third of antibiotics prescribed to pediatric outpatients in Tennessee were optimal for choice and duration. Four stewardship interventions may be targeted: (1) reduce the number of prescriptions for tier 3 diagnoses, (2) increase optimal prescribing for AOM and pharyngitis, (3) provide clinician education on shorter antibiotic treatment courses for community-acquired pneumonia, and (4) promote optimal antibiotic prescribing in resource-limited settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsPractice Patterns, Physicians'HumansCross-Sectional StudiesChildFemaleMaleChild, PreschoolAdolescentInfantTennesseeOutpatientsDrug PrescriptionsAmbulatory CareInappropriate PrescribingGuideline Adherence

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Healthcare-Associated Infections and Antimicrobial Resistance Program of the Communicable and Environmental Diseases and Emergency Preparedness Division, Tennessee Department of Health, Nashville.
  • Division of Infectious Diseases, Department of Pediatrics, University of Utah, Salt Lake City.

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Lehrer, B. J., Mutamba, G., Thure, K. A., Evans, C. D., Hersh, A. L., Banerjee, R., & Katz, S. E. (2024). Optimal Pediatric Outpatient Antibiotic Prescribing. JAMA Network Open, 7(10), e2437409. https://doi.org/10.1001/jamanetworkopen.2024.37409

Vancouver

Lehrer BJ, Mutamba G, Thure KA, Evans CD, Hersh AL, Banerjee R, et al. Optimal Pediatric Outpatient Antibiotic Prescribing. JAMA Network Open. 2024;7(10):e2437409. doi:10.1001/jamanetworkopen.2024.37409

BibTeX
@article{Lehrer2024,
  author = {Lehrer, Brittany J and Mutamba, Glodi and Thure, Katie A and Evans, Christopher D and Hersh, Adam L and Banerjee, Ritu and Katz, Sophie E},
  title = {Optimal Pediatric Outpatient Antibiotic Prescribing},
  journal = {JAMA Network Open},
  year = {2024},
  volume = {7},
  number = {10},
  pages = {e2437409},
  doi = {10.1001/jamanetworkopen.2024.37409}
}
Kostenlos starten →